Suma Krishnan
CIK: 0001298711
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Krystal Biotech, Inc.
Discretionary Trading P&L
Holdings
Transaction History (135 total)
- Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct3.2K shares at avg. $358.42$1.1M - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct520 shares at avg. $354.54$184K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct1.2K shares at avg. $361.61$449K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct1.3K shares at avg. $364.48$484K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct4K shares at avg. $357.57$1.4M - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct826 shares at avg. $365.41$302K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct2K shares at avg. $362.65$722K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct2.3K shares at avg. $360.47$836K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct3.4K shares at avg. $359.39$1.2M - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct3.3K shares at avg. $356.37$1.2M - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct399 shares at avg. $366.56$146K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct565 shares at avg. $363.34$205K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct2K shares at avg. $355.57$713K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct12.7K shares at avg. $307.81$3.9M - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct3.8K shares at avg. $308.89$1.2M - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct400 shares at avg. $304.89$122K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct593 shares at avg. $302.25$179K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct480 shares at avg. $305.87$147K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct2.8K shares at avg. $309.95$868K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct2K shares at avg. $310.94$634K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct240 shares at avg. $311.65$75K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct247 shares at avg. $303.17$75K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct320 shares at avg. $300.75$96K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct1.3K shares at avg. $307.09$414K - Mar 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct589 shares at avg. $258.54$152K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 3,180 | $358.42 | $1,139,777 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 520 | $354.54 | $184,361 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 1,242 | $361.61 | $449,120 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 1,329 | $364.48 | $484,390 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 3,962 | $357.57 | $1,416,709 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 826 | $365.41 | $301,832 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 1,992 | $362.65 | $722,404 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 2,320 | $360.47 | $836,281 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 3,392 | $359.39 | $1,219,038 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 3,267 | $356.37 | $1,164,254 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 399 | $366.56 | $146,256 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 565 | $363.34 | $205,287 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 2,006 | $355.57 | $713,277 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 12,729 | $307.81 | $3,918,070 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 3,803 | $308.89 | $1,174,708 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 400 | $304.89 | $121,958 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 593 | $302.25 | $179,235 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 480 | $305.87 | $146,815 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 2,801 | $309.95 | $868,156 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 2,039 | $310.94 | $634,001 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 240 | $311.65 | $74,796 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 247 | $303.17 | $74,883 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 320 | $300.75 | $96,240 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 1,348 | $307.09 | $413,964 | Direct |
| Mar 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 589 | $258.54 | $152,280 | Direct |
1-25 of 135 transactions
About Krishnan Suma
Krishnan Suma (SEC CIK 0001298711) files insider reports with the SEC as President, R&D of Krystal Biotech, Inc. (KRYS).
Signal8 holds 11 ownership filings by Krishnan Suma, all Form 4s, filed between Sep 13, 2024 and Sep 4, 2026. Those filings report 135 transactions, from Sep 12, 2024 to Sep 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Krishnan Suma's filings is in PITTSBURGH, PA.
Recent filings by Krishnan Suma
Other insiders filing for Krystal Biotech, Inc. (KRYS)
- ROSSI DINO A, Director
- Sutherland Everett Rand, Director
- Mazzacco Catherine, Director
- Mason Christopher, Director
- JANNEY DANIEL, Director
- Gangolli Julian S, Director